Follow the money for ‘Pfizer Tuesday announced it expects to earn $36 billion in revenue this year from its COVID vaccine — an increase from the previous estimate of $33.5 billion.
Pfizer’s COVID vaccine, developed with BioNTech, has quickly become the highest-selling drug in the world. During an earnings call, Pfizer CEO Albert Bourla said the vaccine contributed $13 billion in revenue during the third quarter alone, bringing total revenue this year to $24.3 billion.
Pfizer said its profit margin on the vaccine, before taxes and after splitting profit with BioNTech, is the “high 20s,” which means vaccine profits could approach $10 billion just for Pfizer this year.
The sales estimate for 2021 is equivalent to roughly 80% of what Pfizer believes the rest of its business will earn in 2021.
The company forecasted $29 billion in sales in 2022, based on 1.7 billion doses committed to purchasing contracts. Pfizer said it will manufacture up to 4 billion doses next year, meaning there are 2.3 billion doses it could still sell, Axios reported.’https://childrenshealthdefense.org/defender/pfizer-covid-vaccine-sales-billions/?utm_source=salsa&eType=EmailBlastContent&eId=1101e41b-8057-48a7-9216-5e0e187b9193